Biogen Idec is investigating long-acting, fully-recombinant clotting factors with the potential to empower people with hemophilia to live the lives they choose.
Find out more about our
hemophilia clinical trials
Welcome to
Biogen Idec Hemophilia

Watch our video to learn more about our company and developments in hemophilia

News
Recent news about Biogen Idec's hemophilia therapeutic area

Meetings
National Hemophilia Foundation
Annual Meeting
November 11-13, 2010
New Orleans, LA
American Society of Hematology
ASH Annual Meeting
December 4-7, 2010
Orlando, FL

Click here to
hear from us in the future

Features
Download the
Distance Challenge
Xtreme video game
© Biogen Idec | Terms & Conditions of Use | Note Regarding Forward-Looking Statements | Privacy Policy | Site Map
About | Technology | Hemophilia | Clinical Programs | Community | Careers | Contact Us